An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3

BACKGROUND: In search of new antiparasitic agents for overcoming the limitations of current leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime (6BIO) and several other 6-substituted analogues of indirubin, a naturally occurring bis-indole present in mollusks and...

Descripción completa

Detalles Bibliográficos
Autores principales: Efstathiou, Antonia, Gaboriaud-Kolar, Nicolas, Smirlis, Despina, Myrianthopoulos, Vassilios, Vougogiannopoulou, Konstantina, Alexandratos, Alexandros, Kritsanida, Marina, Mikros, Emmanuel, Soteriadou, Ketty, Skaltsounis, Alexios-Leandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039064/
https://www.ncbi.nlm.nih.gov/pubmed/24886176
http://dx.doi.org/10.1186/1756-3305-7-234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039064/
https://www.ncbi.nlm.nih.gov/pubmed/24886176
http://dx.doi.org/10.1186/1756-3305-7-234

Ejemplares similares